MedTrace Logo

Ginger.io Behavioral Health Study

NCT02491307 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2017-04-25

No results posted yet for this study

Summary

This Study will evaluate the impact of a smartphone-based platform on a range of outcomes for medically-underserved patients with mood disorders (e.g. depression, anxiety, bipolar) cared for in a large statewide community health center. The primary goal of the Study is to reduce emergency room (ER) visits, hospitalizations, and to look at changes in service utilization by using the Ginger.io platform to enhance communication between behavioral health providers and their patients, increasing the early detection of exacerbations in mood disorders (e.g. depression, anxiety, bipolar) and proactive outreach. The secondary goal is to improve clinical \& behavioral health outcomes.

Conditions

Interventions

OTHER

Ginger.io Smartphone Application

Daily use of the Ginger.io smartphone application

Sponsors & Collaborators

  • Ginger.io

    collaborator INDUSTRY

  • Robert Wood Johnson Foundation

    collaborator OTHER

  • Community Health Center, Inc.

    lead INDUSTRY

Principal Investigators

  • David Guggenheim, PsyD · Community Health Center, Inc.

  • Ilan Elson, PhD · Ginger.io

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2015-10-31
Completion
2015-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02491307 on ClinicalTrials.gov